NCT04531345View on ClinicalTrials.gov

Cytokine Status of Covid-19 Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 15, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Flow cytometric analysis

IL-1β, IFN-α2, IFN-γ, TNF-α, MCP-1 (CCL2), IL-6, IL-8 (CXCL8), IL-10, IL-12p70, IL-17A, IL-18, IL-23, IL-33 cytokine analysis of COvid-19 patients and healthy volunteers

Trial Locations (1)

34098

Istanbul Training and Reseach Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Training and Research Hospital

OTHER_GOV

NCT04531345 - Cytokine Status of Covid-19 Patients | Biotech Hunter | Biotech Hunter